3 Reasons to Buy Moderna Stock
Although (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in the COVID-19 vaccine market catapulted it to new heights.
However, once the pandemic began subsiding, with a substantial decline in coronavirus-related sales, Moderna's shares suffered. They're down by 25% over the past three years. Is Moderna just a pandemic stock?
Not at all. Let's consider three reasons why investing in the company today is worth it.
Source Fool.com
Moderna Inc. Stock
€112.88
0.300%
We see a rather positive sentiment for Moderna Inc. with 17 Buy predictions and 2 Sell predictions.
With a target price of 129 € there is a slightly positive potential of 14.28% for Moderna Inc. compared to the current price of 112.88 €.
